Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.3 Billion CNY | 4.05% |
| 2022 | 5.09 Billion CNY | 4.29% |
| 2021 | 4.88 Billion CNY | -1.31% |
| 2020 | 4.95 Billion CNY | 49.21% |
| 2019 | 3.32 Billion CNY | -10.34% |
| 2018 | 3.7 Billion CNY | 10.77% |
| 2017 | 3.34 Billion CNY | 15.71% |
| 2016 | 2.88 Billion CNY | 12.31% |
| 2015 | 2.57 Billion CNY | 12.29% |
| 2014 | 2.29 Billion CNY | 0.65% |
| 2013 | 2.27 Billion CNY | 16.45% |
| 2012 | 1.95 Billion CNY | 23.26% |
| 2011 | 1.58 Billion CNY | 40.54% |
| 2010 | 1.12 Billion CNY | 52.03% |
| 2009 | 742.17 Million CNY | 19.94% |
| 2008 | 618.78 Million CNY | 15.07% |
| 2007 | 537.73 Million CNY | 4.04% |
| 2006 | 516.85 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.91 Billion CNY | 9.54% |
| 2024 Q1 | 5.38 Billion CNY | 1.5% |
| 2024 Q2 | 5.4 Billion CNY | 0.33% |
| 2023 Q1 | 4.94 Billion CNY | -2.97% |
| 2023 FY | 5.3 Billion CNY | 4.05% |
| 2023 Q4 | 5.3 Billion CNY | 3.44% |
| 2023 Q3 | 5.12 Billion CNY | 1.79% |
| 2023 Q2 | 5.03 Billion CNY | 1.85% |
| 2022 Q1 | 4.86 Billion CNY | -0.45% |
| 2022 Q2 | 4.92 Billion CNY | 1.16% |
| 2022 Q4 | 5.09 Billion CNY | 1.07% |
| 2022 Q3 | 5.04 Billion CNY | 2.46% |
| 2022 FY | 5.09 Billion CNY | 4.29% |
| 2021 Q2 | 4.93 Billion CNY | 2.22% |
| 2021 Q1 | 4.82 Billion CNY | -2.63% |
| 2021 Q3 | 4.84 Billion CNY | -1.75% |
| 2021 Q4 | 4.88 Billion CNY | 0.92% |
| 2021 FY | 4.88 Billion CNY | -1.31% |
| 2020 Q4 | 4.95 Billion CNY | -2.32% |
| 2020 Q3 | 5.07 Billion CNY | 47.2% |
| 2020 Q2 | 3.44 Billion CNY | 1.98% |
| 2020 Q1 | 3.37 Billion CNY | 1.76% |
| 2020 FY | 4.95 Billion CNY | 49.21% |
| 2019 Q2 | 3.82 Billion CNY | 0.0% |
| 2019 FY | 3.32 Billion CNY | -10.34% |
| 2019 Q4 | 3.32 Billion CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 3.7 Billion CNY | 10.77% |
| 2017 FY | 3.34 Billion CNY | 15.71% |
| 2016 FY | 2.88 Billion CNY | 12.31% |
| 2015 FY | 2.57 Billion CNY | 12.29% |
| 2014 FY | 2.29 Billion CNY | 0.65% |
| 2013 Q1 | 1.98 Billion CNY | 1.79% |
| 2013 Q3 | 2.14 Billion CNY | 4.23% |
| 2013 FY | 2.27 Billion CNY | 16.45% |
| 2013 Q2 | 2.05 Billion CNY | 3.49% |
| 2012 Q3 | 1.79 Billion CNY | 0.0% |
| 2012 Q1 | 1.65 Billion CNY | 4.33% |
| 2012 Q4 | 1.95 Billion CNY | 8.75% |
| 2012 FY | 1.95 Billion CNY | 23.26% |
| 2011 Q2 | 1.44 Billion CNY | 5.59% |
| 2011 FY | 1.58 Billion CNY | 40.54% |
| 2011 Q4 | 1.58 Billion CNY | 4.54% |
| 2011 Q3 | 1.51 Billion CNY | 5.22% |
| 2011 Q1 | 1.36 Billion CNY | 21.0% |
| 2010 Q4 | 1.12 Billion CNY | 11.59% |
| 2010 FY | 1.12 Billion CNY | 52.03% |
| 2010 Q3 | 1.01 Billion CNY | 0.0% |
| 2009 FY | 742.17 Million CNY | 19.94% |
| 2008 FY | 618.78 Million CNY | 15.07% |
| 2007 FY | 537.73 Million CNY | 4.04% |
| 2006 FY | 516.85 Million CNY | 0.0% |